ArticleCancer management and research2018

A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease.

Chao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.